Literature DB >> 33490281

Protective Role of a New Polysaccharide Extracted from Lonicera japonica Thunb in Mice with Ulcerative Colitis Induced by Dextran Sulphate Sodium.

Xiaonan Zhou1,2, Qingqing Lu3,4, Xiaozhen Kang3,4, Geng Tian3,4, Deguo Ming5, Jialiang Yang3,4.   

Abstract

Lonicera japonica Thunb is a traditional Chinese herbal medicine for treating intestinal inflammation. The extraction method of Lonicera japonica Thunb polysaccharide (LJP) has been developed previously by our research group. In this study, a Fourier transform infrared spectrometer (FT-IR) was used to perform a qualitative analysis of LJP and a precolumn derivatization high-performance liquid chromatography (HPLC) ((Palo Alto, CA, USA) method was used to explore the monosaccharide composition of LJP. Then, we studied the effect of LJP on the intestinal flora and immune functions of dextran sulfate sodium- (DSS-) induced colitis ulcerative mouse models. The results showed that LJP was consisted of 6 types of monosaccharides and had the characteristic absorption of typical polysaccharides. LJP can increase significantly the weight, organ index, serum cytokines (interleukin, tumor necrosis factor, and interferon-γ), secretory immunoglobulin A (SIgA) concentration, and natural killer (NK) cell and cytotoxic lymphocyte (CTL) activities in DSS-treated mice. The results of intestinal flora showed that a high dose (150 mg kg-1) of LJP had the best effects on improving the intestinal probiotics (Bifidobacterium and Lactobacilli) and antagonizing the pathogenic bacteria (Escherichia coli and Enterococcus). In addition, the measurement results of the spleen lymphocyte apoptosis confirmed from another perspective that LJP had protective effects of immune cells for DSS-treated mice.
Copyright © 2021 Xiaonan Zhou et al.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33490281      PMCID: PMC7801063          DOI: 10.1155/2021/8878633

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


  46 in total

1.  Impact of chronic conditions on quality of life in patients with inflammatory bowel disease.

Authors:  Laura T Pizzi; Christine M Weston; Neil I Goldfarb; Deborah Moretti; Nicole Cobb; Jamie B Howell; Anthony Infantolino; Anthony J Dimarino; Sidney Cohen
Journal:  Inflamm Bowel Dis       Date:  2006-01       Impact factor: 5.325

2.  Reinforcement of the intestinal mucus layer protects against Clostridium difficile intestinal injury in vitro.

Authors:  Lawrence N Diebel; David M Liberati
Journal:  J Am Coll Surg       Date:  2014-05-20       Impact factor: 6.113

3.  Cerebral sinus thrombosis occurring in a patient with ulcerative colitis treated with the Chinese herbal medicine YanNan BaiYao.

Authors:  A Kamdar; A Alsafi; O Halse
Journal:  QJM       Date:  2012-07-13

4.  Vaccinium bracteatum Thunb. Leaves' polysaccharide alleviates hepatic gluconeogenesis via the downregulation of miR-137.

Authors:  Hai-Feng Qian; Yan Li; Li Wang
Journal:  Biomed Pharmacother       Date:  2017-09-21       Impact factor: 6.529

5.  A new nucleic acid-based agent inhibits cytotoxic T lymphocyte-mediated immune disorders.

Authors:  Chuang-Wei Wang; Wen-Hung Chung; Yi-Fang Cheng; Nien-Wen Ying; Konan Peck; Yuan-Tsong Chen; Shuen-Iu Hung
Journal:  J Allergy Clin Immunol       Date:  2013-06-19       Impact factor: 10.793

6.  Peptidoglycan recognition proteins protect mice from experimental colitis by promoting normal gut flora and preventing induction of interferon-gamma.

Authors:  Sukumar Saha; Xuefang Jing; Shin Yong Park; Shiyong Wang; Xinna Li; Dipika Gupta; Roman Dziarski
Journal:  Cell Host Microbe       Date:  2010-08-19       Impact factor: 21.023

7.  Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease.

Authors:  A V Weizman; E Ahn; R Thanabalan; W Leung; K Croitoru; M S Silverberg; A Hillary Steinhart; G C Nguyen
Journal:  Aliment Pharmacol Ther       Date:  2011-12-18       Impact factor: 8.171

Review 8.  Role of the tumor microenvironment in regulating apoptosis and cancer progression.

Authors:  Katherine Yaacoub; Remy Pedeux; Karin Tarte; Thierry Guillaudeux
Journal:  Cancer Lett       Date:  2016-05-17       Impact factor: 8.679

9.  Protective effect of polysaccharides from Angelica sinensis on ulcerative colitis in rats.

Authors:  V K C Wong; L Yu; C H Cho
Journal:  Inflammopharmacology       Date:  2008-08       Impact factor: 4.473

Review 10.  T-cell apoptosis in autoimmune diseases: termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms.

Authors:  R Gold; H P Hartung; H Lassmann
Journal:  Trends Neurosci       Date:  1997-09       Impact factor: 13.837

View more
  6 in total

Review 1.  Natural compounds as safe therapeutic options for ulcerative colitis.

Authors:  Mukta Gupta; Vijay Mishra; Monica Gulati; Bhupinder Kapoor; Amrinder Kaur; Reena Gupta; Murtaza M Tambuwala
Journal:  Inflammopharmacology       Date:  2022-02-25       Impact factor: 4.473

Review 2.  Influence of Natural Polysaccharides on Intestinal Microbiota in Inflammatory Bowel Diseases: An Overview.

Authors:  Qi Li; Linyan Li; Qiqiong Li; Junqiao Wang; Shaoping Nie; Mingyong Xie
Journal:  Foods       Date:  2022-04-09

3.  Evaluation of prophylactic efficacy of cinnamaldehyde in murine model against Paradendryphiella arenariae mycotoxin tenuazonic acid-induced oxidative stress and organ toxicity.

Authors:  Ankita Kumari; Karuna Singh
Journal:  Sci Rep       Date:  2021-09-30       Impact factor: 4.379

4.  Intrauterine Growth Retardation Affects Intestinal Health of Suckling Piglets via Altering Intestinal Antioxidant Capacity, Glucose Uptake, Tight Junction, and Immune Responses.

Authors:  Xiaopeng Tang; Kangning Xiong
Journal:  Oxid Med Cell Longev       Date:  2022-03-19       Impact factor: 6.543

Review 5.  Traditional Chinese Medicine and Natural Products: Potential Approaches for Inflammatory Bowel Disease.

Authors:  Shuo Yuan; You Li; Jiao Li; Jia-Chen Xue; Qi Wang; Xiao-Ting Hou; Huan Meng; Ji-Xing Nan; Qing-Gao Zhang
Journal:  Front Pharmacol       Date:  2022-07-07       Impact factor: 5.988

Review 6.  Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review.

Authors:  Zhi-Hua Yang; Bin Wang; Qian Ma; Lin Wang; Ya-Xin Lin; Hai-Feng Yan; Zi-Xuan Fan; Hao-Jia Chen; Zhao Ge; Feng Zhu; Hui-Jie Wang; Bao-Nan Zhang; Hai-Dong Sun; Li-Min Feng
Journal:  Front Pharmacol       Date:  2021-07-15       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.